Posts by VIVA! Communications
93 per cent of Aussies recognise benefits of flu shot in pharmacy – Pharmacy Guild of Australia
Federal Health Minister supports pharmacy as flu vaccination hub with flu shots expected to climb by almost one million this year The majority (93 per cent) of Australian adults recognise the benefits of flu vaccination in pharmacy, citing access, cost and convenience as the biggest motivators for protecting against seasonal influenza.1 This is according to…
Read MoreAre you aware of Lynch Syndrome? – Worldwide Lynch Syndrome Awareness Day
Today is Lynch Syndrome Awareness Day. For those who haven’t heard of the condition, Lynch syndrome, previously known as HNPCC, is an inherited genetic mutation. It gives people an increased chance of developing certain cancers across their lifetime, often at a younger age than the general population, i.e., before 50 years of age. The most…
Read MoreWomen encouraged to check their heart health
The classical image of a heart attack is that of a man battling to breathe, crippled in pain. However new research published in British Medical Journal, Heart, on March 1, 2017, reveals Australian women are less likely to be screened for heart disease than men. The new research, entitled, Gender inequalities in cardiovascular risk factor…
Read MoreRecognising Brain Awareness Week in Australia – Top Tips for a Healthy Mind
Today marks the start of the Global Brain Awareness Week. Running from the 13th to 19th of March, Brain Awareness Week aims to raise public cognizance of 80+ disorders that affect the brain. Some of the most common and well known neurological diseases include multiple sclerosis, Alzheimer’s, Parkinson’s Disease and stroke. Here are the…
Read MoreAustralia’s only locally manufactured QIV now available for the 2017 influenza season
Afluria Quad™ (inactivated quadrivalent seasonal influenza vaccine (split virion)) (QIV), Australia’s only locally manufactured influenza vaccine, is now available for use in the private market. Afluria Quad™ – indicated for use in persons aged 18 years and over1 – is also listed on the National Immunisation Program (NIP) for the 2017 influenza season.2 Afluria Quad™…
Read More